| Blood loss after cesarean delivery: a registry-based study in Norway, 1999-2008. | |
| | |
MedLine Citation:
|
PMID: 21963102 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVE: The objective of the study was to assess risk factors for moderate and severe blood loss after cesarean delivery (CD). STUDY DESIGN: All planned (n = 32,716) and emergency (n = 47,942) cesareans, as reported over a 10-year period to the Medical Birth Registry of Norway, were analyzed separately in a case-control design. Women with moderate (500 to ≤1500 mL) or severe (>1500 mL) blood loss were analyzed with women with blood loss less than 500 mL as controls in SPSS (version 17.0) with χ(2) test and logistic regression. RESULTS: The prevalence of severe blood loss was consistently higher in emergency (3.2%) than planned CD (1.9%). Planned and emergency CDs share common risk factors for both moderate and severe blood loss, whereas emergency CD carries in addition delivery-related risk factors. CONCLUSION: When revising management schemes for CD, anesthetic procedures should be reconsidered as surgical competence in cases with placenta previa, placental abruption, and low hemoglobin. |
| | |
Authors:
|
Finn Egil Skjeldestad; Pål Oian |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-7-30 |
Journal Detail:
|
Title: American journal of obstetrics and gynecology Volume: - ISSN: 1097-6868 ISO Abbreviation: - Publication Date: 2011 Jul |
Date Detail:
|
Created Date: 2011-10-3 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370476 Medline TA: Am J Obstet Gynecol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Mosby, Inc. All rights reserved. |
Affiliation:
|
Department of Clinical Medicine, University of Tromsø, Tromsø, Norway. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Selenium in reproductive health.
Next Document: Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome.